VEGF inhibition could temporarily restore or normalize the function of tumor-associated vasculature, decreasing vascular permeability in conjunction with restoration of sustained pressure gradients, thereby enhancing systemic delivery of oxygen or perfusion of cytotoxic agents to intratumoral sites. This evidence concerns the gene VEGFA and neoplasm.